The Top Line cover image

Misconduct and the future of neurodegenerative disease research

The Top Line

00:00

Challenges and Future Directions in Parkinson's Drug Targeting

This chapter explores the challenges of targeting alpha-synuclein in Parkinson's disease and evaluates the limitations of current immunotherapy strategies. It highlights the need for innovative approaches in drug development to effectively address this complex target in neurodegenerative treatments.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app